Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

227
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
227
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

152
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
152
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

842
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes Technology Trends: A Review of the Latest Innovations.

The Journal of clinical endocrinology and metabolism·2025
Same author

Editorial: A Guidebook for Providers on Comprehensive Diabetes Care.

The Journal of clinical endocrinology and metabolism·2025
Same author

Mind Matters: Mental Health and Diabetes Management.

The Journal of clinical endocrinology and metabolism·2025
Same author

Navigating Insulin Options for Diabetes Management.

The Journal of clinical endocrinology and metabolism·2025
Same author

Role of Diabetes Self-management Education for Our Health Systems and Economy.

The Journal of clinical endocrinology and metabolism·2025
Same author

Tailoring Exercise Prescription for Effective Diabetes Glucose Management.

The Journal of clinical endocrinology and metabolism·2025

Related Experiment Video

Updated: May 26, 2025

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

416

Trending Modalities in Type 2 Diabetes Prevention.

Erika L Lundgrin1,2,3, Betul Hatipoglu2,3

  • 1Department of Pediatric Endocrinology, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA.

The Journal of Clinical Endocrinology and Metabolism
|February 25, 2025
PubMed
Summary
This summary is machine-generated.

Preventing type 2 diabetes (T2D) is crucial as prediabetes affects many. New strategies, including lifestyle changes, medications, fecal transplants, and incretin agents, offer promising avenues for T2D prevention.

Keywords:
prediabetespreventiontype 2 diabetes mellitusβ cell

More Related Videos

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.6K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.7K

Related Experiment Videos

Last Updated: May 26, 2025

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

416
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.6K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.7K

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Microbiome Research

Background:

  • Prediabetes prevalence is increasing, posing a significant risk for type 2 diabetes (T2D) development.
  • Type 2 diabetes (T2D) has substantial impacts on morbidity and mortality, underscoring the importance of prevention.

Purpose of the Study:

  • To review current and emerging strategies for the prevention of type 2 diabetes (T2D).
  • To highlight the growing number of novel therapeutic approaches for T2D prevention.

Main Methods:

  • Systematic search of PubMed and Ovid MEDLINE databases.
  • Inclusion of systematic reviews, meta-analyses, and original research articles.
  • Focus on prediabetes and type 2 diabetes (T2D) prevention.

Main Results:

  • Intensive lifestyle modification and insulin resistance-improving medications are established T2D prevention strategies.
  • Emerging strategies include fecal microbiota transplantation for its potential role in diabetes prevention.
  • Incretin-based pharmaceutical agents show promise for both prevention and treatment of T2D.

Conclusions:

  • The landscape of T2D prevention is rapidly evolving with novel therapeutic options.
  • Understanding the indications, outcomes, and limitations of new T2D prevention therapies is essential for clinicians.